Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers
Condition: Bioequivalence Interventions: Drug: Oseltamivir Phosphate 75 mg capsules; Drug: Tamiflu capsules 75 mg Sponsor: Austarpharma, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2020 Category: Research Source Type: clinical trials
